Safety of trastuzumab in women with HER2+breast cancer.

被引：1
|
作者：
Nowsheen, Somaira
Aziz, Khaled
Park, Jae Yoon
Villarraga, Hector R.
Herrmann, Joerg
Ruddy, Kathryn Jean
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e12522
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12522
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+breast cancer.
    Esfahani, Khashayar
    Ferrario, Cristiano
    Le, Philippe
    Panasci, Lawrence C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] STAT6 expression and trastuzumab resistance in HER2+breast cancer.
    Cobleigh, Melody A.
    DiScala, Molly
    Najor, Matthew S.
    Yung, Timothy
    Abukhdeir, Abde M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Adjuvant trastuzumab and vinorelbine (TV) for early-stage HER2+breast cancer.
    McLaughlin, Shannon
    Nakajima, Erika
    Isakoff, Steven J.
    Shin, Jennifer
    Moy, Beverly
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Impact of mastectomy in women with stage IV HER2+breast cancer.
    Babar, Arslan
    Covut, Fahrettin
    Kewan, Tariq Zuheir
    Rahman, Shafia
    Grobmeyer, Stephen R.
    Montero, Alberto J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Factors associated with non use of adjuvant trastuzumab in older patients with HER2+breast cancer.
    Luis, Ines Vaz
    Lin, Nancy U.
    Keating, Nancy Lynn
    Barry, William Thomas
    Lii, Joyce
    Burstein, Harold J.
    Winer, Eric P.
    Freedman, Rachel A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2+breast cancer.
    Garrison, L. P., Jr.
    Perez, E. A.
    Dueck, A.
    Lalla, D.
    Paton, V.
    Lubeck, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 306S - 306S
  • [7] TRASTUZUMAB INDUCED CARDIOTOXICITY IN PATIENTS WITH HER2+BREAST CANCER
    Santamaria Elena, Capilla
    Garcia Beatriz, Benitez
    Jose Antonio, Romero Garrido
    Aunon Pilar, Zamora
    Abad Gema, Casado
    del Valle Luis, Gonzalez
    Ambrosio Alicia, Herrero
    [J]. ATENCION FARMACEUTICA, 2013, 15 (04): : 261 - 267
  • [8] Targeting glucose metabolism in HER2+breast cancer.
    Chang, Simone
    Chesney, Jason
    Trent, John O.
    Telang, Sucheta
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [9] Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+Breast Cancer
    Munoz, Caroline
    Tai, Xiaochen
    Arias, Jessica
    Eisen, Andrea
    Chaudhry, Munaza
    Gavura, Scott
    Chan, Kelvin K. W.
    [J]. CURRENT ONCOLOGY, 2024, 31 (03) : 1633 - 1644
  • [10] Risk of Heart Failure after Radiotherapy in Women with HER2+Breast Cancer Treated with Trastuzumab
    Aziz, K.
    Nowsheen, S.
    Herrmann, J.
    Ruddy, K. J.
    Mutter, R. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E39 - E40
12345